Through comprehensive analysis of multiple omics data and rigorous validation of clinical data, our findings not only underscored the robust association between the upregulation of LOX family expression and unfavourable prognosis, as well as poor response to chemotherapy, targeted therapy and immunotherapy but also revealed numerous potential mechanisms governing LOX family regulation within the cancer milieu. This evidence concerns the gene LOX and cancer.